Serum Lactate Dehydrogenase is a Predictive Biomarker in Oropharyngeal Cancer Patients Undergoing Radiotherapy.

MLA

Uehara, T., et al. “Serum Lactate Dehydrogenase Is a Predictive Biomarker in Oropharyngeal Cancer Patients Undergoing Radiotherapy.” International Journal of Radiation Oncology, Biology, Physics, vol. 111, no. 3, Nov. 2021, pp. e397–98. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2021.07.1153.

APA

Uehara, T., Doi, H., Ishikawa, K., Tatsuno, S., Wada, Y., Oguma, Y., Inada IV, M., Nakamatsu, K., Hosono, M., Nishimura, Y., & Inada, M. 4th. (2021). Serum Lactate Dehydrogenase is a Predictive Biomarker in Oropharyngeal Cancer Patients Undergoing Radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 111(3), e397–e398. https://doi.org/10.1016/j.ijrobp.2021.07.1153

Chicago

Uehara, T., H. Doi, K. Ishikawa, S. Tatsuno, Y. Wada, Y. Oguma, M. Inada IV, et al. 2021. “Serum Lactate Dehydrogenase Is a Predictive Biomarker in Oropharyngeal Cancer Patients Undergoing Radiotherapy.” International Journal of Radiation Oncology, Biology, Physics 111 (3): e397–98. doi:10.1016/j.ijrobp.2021.07.1153.